Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $110,260 - $131,240
965 Added 61.82%
2,526 $310,000
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $750,056 - $893,365
-6,148 Reduced 79.75%
1,561 $202,000
Q2 2023

Feb 22, 2024

BUY
$122.5 - $147.16 $106,697 - $128,176
871 Added 19.46%
5,347 $662,000
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $28,420 - $34,141
-232 Reduced 2.92%
7,709 $955,000
Q1 2023

Feb 22, 2024

BUY
$133.98 - $160.47 $261,260 - $312,916
1,950 Added 77.2%
4,476 $654,000
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $45,419 - $54,399
-339 Reduced 4.09%
7,941 $1.16 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $463,619 - $571,303
-3,574 Reduced 30.15%
8,280 $1.32 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $1.5 Million - $1.91 Million
11,854 New
11,854 $1.58 Million
Q1 2021

May 13, 2021

SELL
$150.19 - $173.5 $501,484 - $579,316
-3,339 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $469,830 - $551,101
3,339 New
3,339 $551,000
Q3 2020

Nov 12, 2020

SELL
$105.46 - $144.13 $209,970 - $286,962
-1,991 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$95.68 - $121.88 $190,498 - $242,663
1,991 New
1,991 $220,000
Q1 2020

May 11, 2020

SELL
$87.74 - $152.74 $519,245 - $903,915
-5,918 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$117.65 - $153.73 $304,831 - $398,314
2,591 Added 77.88%
5,918 $883,000
Q3 2019

Nov 12, 2019

BUY
$125.18 - $143.24 $416,473 - $476,559
3,327 New
3,327 $426,000
Q4 2018

Feb 14, 2019

SELL
$115.94 - $166.74 $170,663 - $245,441
-1,472 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $37,676 - $42,253
-234 Reduced 13.72%
1,472 $247,000
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $249,638 - $312,505
1,706 New
1,706 $294,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.